Spillover effects of Medicaid expansion on insurance coverage, diagnosis, and survival among low-income elderly patients with cancer. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting ...
An op-ed published by MedPage Today in 2023 that called for more aggressive enforcement of the data reporting law said the ...
Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...
Establishing a protocol to increase racial/ethnic minority enrollment on an active radiation oncology randomized clinical trial. Background: Racial and ethnic minority populations are underrepresented ...
The HealthVerity agreement is the latest in a series of data partnerships through which Thermo Fisher has been expanding its ...
A recent FDA crackdown highlights transparency issues in clinical research, as thousands of companies and researchers have ...
A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...
Fred Hutch’s health services researcher Joe Unger, PhD, MS, working with the American Society of Clinical Oncology (ASCO), the U.S. Food & Drug Administration (FDA) and the Friends of Cancer Research, ...
To access the results of clinical trials, researchers use “endpoints,” specific events or outcomes that help evaluate the benefit of the intervention under investigation. Traditionally, overall ...
Nature Communications is interested in publishing high-quality clinical research in all areas of medicine. In this call for papers, we are inviting submissions of papers reporting interventional ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results